补肾活血方对多囊卵巢综合征促排卵患者卵泡发育及妊娠的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R711.75

基金项目:

浙江省中医药管理局A类项目(2018ZA096);杭州市科技计划项目(20191203B131)


Effect of Bushen Huoxue Prescription on Follicular Development and Pregnancy in Patients with Polycystic Ovary Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:研究补肾活血方与促排卵药物联合使用对肾虚血瘀型多囊卵巢综合征患者血清雌二醇激素(E2)、子宫内膜厚度、血清抗缪勒氏激素(AMH) 以及排卵率、受孕率的影响。方法:将符合纳入标准的肾虚血瘀型多囊卵巢综合征患者78 例随机分成2 组各39 例。对照组予克罗米芬并在人绒毛膜促性腺激素(HCG) 注射日注射HCG 5 000~10 000 U;联合用药组在对照组用药的基础上加用补肾活血方治疗。2 组均治疗3 个月经周期评价疗效。治疗前后检测血清E2、AMH 水平并测量HCG 注射日子宫内膜厚度,随访并统计入选病例最终的排卵率、受孕率,对收集的数据进行综合分析。结果:治疗后,2 组血清E2 分别与治疗前比较,差异均无统计学意义(P>0.05),2 组血清E2 比较,差异无统计学意义(P>0.05)。治疗后,注射HCG 当天血清E2 均高于注射前,且联合用药组高于对照组,差异均有统计学意义(P<0.01)。治疗后HCG 注射日子宫内膜厚度联合用药组(9.37±3.04) mm,对照组(6.60±2.19) mm,2 组比较,差异有统计学意义(P<0.01)。治疗后,2 组血清AMH 分别与治疗前比较,差异均无统计学意义(P>0.05);治疗后,联合用药组AMH 低于对照组,差异有统计学意义(P<0.05)。治疗后,联合用药组排卵率及受孕率分别与对照组比较,差异均有统计学意义(P<0.05),联合用药组优于对照组。结论:补肾活血方可以有效提高肾虚血瘀型多囊卵巢综合征患者HCG 注射日E2水平、子宫内膜厚度,从而提高排卵率,改善受孕率。

    Abstract:

    Abstract: Objective: To study the effect of the therapy of Bushen Huoxue prescription combined with ovulation induction medicines on serum estradiol(E2), endometrial thickness, serum anti- mullerian hormone(AMH), and rates of ovulation and pregnancy in patients with polycystic ovary syndrome of kidney deficiency and blood stasis type. Methods:A total of 78 polycystic ovary syndrome patients who met the inclusion criteria were randomly divided into two groups,with 39 cases in each group. The control group was treated with clomiphene and 5 000-10 000 U of HCG was injected on the day of HCG injection; the combined administration group was additionally treated with Bushen Huoxue tang based on the treatment of the control group. Both groups were treated for three menstrual cycles,and the curative effects were evaluated after treatment. Serum levels of E2 and AMH before and after treatment were detected,and endometrial thickness on HCG injection day was measured. The final rates of ovulation and pregnancy of selected cases were followed up and counted,and the collected data were comprehensively analyzed. Results: Compared with the same group, there was no significant difference being found in the comparison of serum E2 before and after treatment(P>0.05),and after treatment,there was no significant difference being found in the comparison of serum E2 between the two groups(P>0.05). After treatment, the serum E2 levels in the two groups on the day of HCG injection were higher than those before injection,and the above level in the combined administration group was higher than that in the control group, differences being significant(P<0.01). After treatment, the endometrial thickness on the day of HCG injection was(9.37 ± 3.04) mm in the combined administration group,and(6.60±2.19) mm in the control group,the difference being significant(P<0.01). Compared with the same group, there was no significant difference being found in the comparison of serum AMH before and after treatment(P>0.05);after treatment,the level of AMH in the combined administration group was lower than that in the control group,the difference being significant(P<0.05). After treatment,the differences between the rates of ovulation and pregnancy in the two group were significant(P<0.05), and the above rates in the combined administration group were better than those in the control group. Conclusion: Bushen Huoxue prescription can effectively improve the E2 level and endometrial thickness on HCG injection day in patients with polycystic ovary syndrome of kidney deficiency and blood stasis type,so as to increase the rates of ovulation and pregnancy.

    参考文献
    相似文献
    引证文献
引用本文

杨岳,万凌屹,丁彩飞.补肾活血方对多囊卵巢综合征促排卵患者卵泡发育及妊娠的影响[J].新中医,2022,54(2):121-125

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-01-22
  • 出版日期:
文章二维码